PRA Health Sciences Stock Price, News & Analysis (NASDAQ:PRAH)

$80.70 0.80 (1.00 %)
(As of 11/17/2017 04:00 PM ET)
Previous Close$79.90
Today's Range$78.99 - $80.84
52-Week Range$51.16 - $84.38
Volume383,938 shs
Average Volume533,470 shs
Market Capitalization$4.96882 billion
P/E Ratio28.83
Dividend YieldN/A
Beta0.43

About PRA Health Sciences (NASDAQ:PRAH)

PRA Health Sciences logoPRA Health Sciences, Inc. is a contract research organization. The Company provides outsourced clinical development services to the biotechnology and pharmaceutical industries. The Company offers therapeutic services in areas of pharmaceutical development, including oncology, central nervous system, inflammation and infectious diseases. Its services include data management, statistical analysis, clinical trial management, and regulatory and drug development consulting. It provides its clients with clinical development service offerings, which includes both traditional, project-based Phase I through Phase IV services, as well as embedded and functional outsourcing services. As of December 31, 2016, its clinical development platform included approximately 70 offices across North America, Europe, Asia, Latin America, South Africa, Australia and the Middle East. The Company's service offerings include product registration, strategic solutions and early development services.


Industry, Sector and Symbol:
  • Industry: Biotechnology & Medical Research
  • Sub-Industry: N/A
  • Sector: Medical
  • Symbol: NASDAQ:PRAH
  • CUSIP: N/A
  • Web: www.prahs.com
Debt:
  • Debt-to-Equity Ratio: 1.38%
  • Current Ratio: 1.01%
  • Quick Ratio: 1.01%
Price-To-Earnings:
  • Trailing P/E Ratio: 28.83
  • Forward P/E Ratio: 25.22
  • P/E Growth: 1.36
Sales & Book Value:
  • Annual Sales: $1.81171 billion
  • Price / Sales: 2.82
  • Cash Flow: $3.95 per share
  • Price / Cash: 20.42
  • Book Value: $14.77 per share
  • Price / Book: 5.46
Profitability:
  • Trailing EPS: $1.79
  • Net Income: $68.17 million
  • Net Margins: 5.64%
  • Return on Equity: 21.66%
  • Return on Assets: 7.02%
Misc:
  • Employees: 13,000
  • Outstanding Shares: 63,370,000
 
Frequently Asked Questions for PRA Health Sciences (NASDAQ:PRAH)

What is PRA Health Sciences' stock symbol?

PRA Health Sciences trades on the NASDAQ under the ticker symbol "PRAH."

How were PRA Health Sciences' earnings last quarter?

PRA Health Sciences, Inc. (NASDAQ:PRAH) issued its earnings results on Wednesday, October, 25th. The medical research company reported $0.88 EPS for the quarter, topping the consensus estimate of $0.85 by $0.03. The medical research company had revenue of $494.55 million for the quarter, compared to the consensus estimate of $477.89 million. PRA Health Sciences had a net margin of 5.64% and a return on equity of 21.66%. The firm's revenue for the quarter was up 23.7% on a year-over-year basis. During the same period in the previous year, the firm earned $0.64 earnings per share. View PRA Health Sciences' Earnings History.

What guidance has PRA Health Sciences issued on next quarter's earnings?

PRA Health Sciences issued an update on its FY17 earnings guidance on Wednesday, October, 25th. The company provided earnings per share (EPS) guidance of $3.28-3.35 for the period, compared to the Thomson Reuters consensus EPS estimate of $3.20. The company issued revenue guidance of $1.914-1.926 billion, compared to the consensus revenue estimate of $1.89 billion.

Where is PRA Health Sciences' stock going? Where will PRA Health Sciences' stock price be in 2017?

10 brokerages have issued twelve-month price targets for PRA Health Sciences' shares. Their forecasts range from $63.00 to $101.00. On average, they anticipate PRA Health Sciences' share price to reach $88.60 in the next year. View Analyst Ratings for PRA Health Sciences.

Who are some of PRA Health Sciences' key competitors?

Who are PRA Health Sciences' key executives?

PRA Health Sciences' management team includes the folowing people:

  • Colin Shannon, Chairman of the Board, President, Chief Executive Officer (Age 57)
  • Linda Baddour, Chief Financial Officer, Executive Vice President (Age 58)
  • David W. Dockhorn Ph.D., Executive Vice President, Corporate Compliance Officer (Age 56)
  • Max C. Lin, Director (Age 36)
  • James C. Momtazee, Director (Age 45)
  • Ali J. Satvat, Director (Age 39)
  • Jeffrey T. Barber, Independent Director (Age 64)
  • Alexander George Dickinson Ph.D., Independent Director

When did PRA Health Sciences IPO?

(PRAH) raised $306 million in an initial public offering on Thursday, November 13th 2014. The company issued 17,000,000 shares at $18.00 per share. Jefferies, Citigroup, KKR, UBS Investment Bank, Credit Suisse and Wells Fargo Securities acted as the underwriters for the IPO and Baird and William Blair were co-managers.

Who owns PRA Health Sciences stock?

PRA Health Sciences' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Wells Fargo & Company MN (1.90%), Eagle Asset Management Inc. (1.74%), Russell Investments Group Ltd. (1.44%), Ameriprise Financial Inc. (1.32%), Hood River Capital Management LLC (1.29%) and Pictet Asset Management Ltd. (0.91%). Company insiders that own PRA Health Sciences stock include Colin Shannon, David W Dockhorn, Linda Baddour and Pra Investors LP Kkr. View Institutional Ownership Trends for PRA Health Sciences.

Who sold PRA Health Sciences stock? Who is selling PRA Health Sciences stock?

PRA Health Sciences' stock was sold by a variety of institutional investors in the last quarter, including Prudential Financial Inc., Allianz Asset Management GmbH, TimesSquare Capital Management LLC, Old Mutual Global Investors UK Ltd., Mesirow Financial Investment Management Equity Management, BNP Paribas Arbitrage SA, Pura Vida Investments LLC and Bellecapital International Ltd.. Company insiders that have sold PRA Health Sciences company stock in the last year include Colin Shannon, David W Dockhorn, Linda Baddour and Pra Investors LP Kkr. View Insider Buying and Selling for PRA Health Sciences.

Who bought PRA Health Sciences stock? Who is buying PRA Health Sciences stock?

PRA Health Sciences' stock was purchased by a variety of institutional investors in the last quarter, including Wells Fargo & Company MN, Stephens Investment Management Group LLC, Neuberger Berman Group LLC, Hood River Capital Management LLC, Schwab Charles Investment Management Inc., Vaughan Nelson Investment Management L.P., Bank of New York Mellon Corp and Magnetar Financial LLC. View Insider Buying and Selling for PRA Health Sciences.

How do I buy PRA Health Sciences stock?

Shares of PRA Health Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is PRA Health Sciences' stock price today?

One share of PRA Health Sciences stock can currently be purchased for approximately $80.70.

How big of a company is PRA Health Sciences?

PRA Health Sciences has a market capitalization of $4.96882 billion and generates $1.81171 billion in revenue each year. The medical research company earns $68.17 million in net income (profit) each year or $1.79 on an earnings per share basis. PRA Health Sciences employs 13,000 workers across the globe.

How can I contact PRA Health Sciences?

PRA Health Sciences' mailing address is 4130 PARKLAKE AVENUE SUITE 400, RALEIGH NC, 27612. The medical research company can be reached via phone at 919-786-8200 or via email at [email protected]


MarketBeat Community Rating for PRA Health Sciences (NASDAQ PRAH)
Community Ranking:  2.9 out of 5 (star star)
Outperform Votes:  170 (Vote Outperform)
Underperform Votes:  128 (Vote Underperform)
Total Votes:  298
MarketBeat's community ratings are surveys of what our community members think about PRA Health Sciences and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Analysts' Consensus Ratings for PRA Health Sciences (NASDAQ:PRAH) (How are Consensus Ratings Calculated?)
Ratings Breakdown: 0 Sell Ratings, 1 Hold Rating, 9 Buy Ratings, 0 Strong Buy Ratings
Consensus Rating:Buy (Score: 2.90)
Consensus Price Target: $88.60 (9.79% upside)
Consensus Price Target History for PRA Health Sciences (NASDAQ:PRAH)
Price Target History for PRA Health Sciences (NASDAQ:PRAH)
Analysts' Ratings History for PRA Health Sciences (NASDAQ:PRAH)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
10/30/2017KeyCorpReiterated RatingBuy$86.00 -> $93.00N/AView Rating Details
10/27/2017SunTrust Banks, Inc.Reiterated RatingBuy$101.00N/AView Rating Details
10/26/2017Credit Suisse GroupBoost Price TargetOutperform$90.00 -> $93.00N/AView Rating Details
10/26/2017Jefferies Group LLCReiterated RatingBuy$95.00N/AView Rating Details
10/9/2017Robert W. BairdReiterated RatingBuy$88.00N/AView Rating Details
9/21/2017MizuhoInitiated CoverageBuy$82.00LowView Rating Details
8/16/2017Raymond James Financial, Inc.Initiated CoverageOutperform -> Outperform$89.00LowView Rating Details
8/10/2017Citigroup Inc.Reiterated RatingBuy$90.00 -> $93.00LowView Rating Details
6/26/2017Bank of America CorporationInitiated CoverageBuy$89.00LowView Rating Details
2/27/2017Avondale PartnersUpgradeUnderperform -> Market Perform$63.00N/AView Rating Details
6/20/2016First AnalysisInitiated CoverageEqual -> Equal Weight$47.00N/AView Rating Details
(Data available from 11/17/2015 forward)

Earnings

Earnings History for PRA Health Sciences (NASDAQ:PRAH)
Earnings by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Earnings History by Quarter for PRA Health Sciences (NASDAQ PRAH)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
10/25/2017Q3 2017$0.85$0.88$477.89 million$494.55 millionViewN/AView Earnings Details
8/7/2017Q2 2017$0.72$0.62$447.79 million$457.90 millionViewListenView Earnings Details
4/25/2017Q1 2017$0.58$0.60$426.81 million$427.08 millionViewN/AView Earnings Details
2/22/2017Q4 2016$0.64$0.71$405.04 million$413.61 millionViewN/AView Earnings Details
11/2/2016Q316$0.64$0.64$394.87 million$399.80 millionViewN/AView Earnings Details
7/28/2016Q2$0.59$0.63$381.25 million$394.20 millionViewListenView Earnings Details
4/27/2016Q116$0.53$0.55$372.21 million$372.30 millionViewListenView Earnings Details
2/24/2016Q4$0.49$0.59$353.42 million$428.90 millionViewListenView Earnings Details
11/2/2015Q3$0.45$0.52$346.05 million$345.10 millionViewListenView Earnings Details
7/27/2015Q215$0.40$0.47$336.74 million$336.50 millionViewListenView Earnings Details
5/6/2015Q115$0.31$0.41$329.80 million$332.00 millionViewListenView Earnings Details
2/18/2015Q414$0.30$0.35$323.50 million$370.00 millionViewListenView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for PRA Health Sciences (NASDAQ:PRAH)
2017 EPS Consensus Estimate: $3.10
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$0.57$0.66$0.62
Q2 20173$0.68$0.79$0.73
Q3 20174$0.80$0.83$0.82
Q4 20174$0.85$1.00$0.94
Q2 20181$0.92$0.92$0.92
Q3 20181$1.05$1.05$1.05
(Data provided by Zacks Investment Research)

Dividends

Dividend History for PRA Health Sciences (NASDAQ:PRAH)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for PRA Health Sciences (NASDAQ PRAH)
Insider Ownership Percentage: 2.10%
Institutional Ownership Percentage: 97.60%
Insider Trades by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Institutional Ownership by Quarter for PRA Health Sciences (NASDAQ:PRAH)
Insider Trades by Quarter for PRA Health Sciences (NASDAQ PRAH)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/14/2017Colin ShannonCEOSell400,000$74.85$29,940,000.00View SEC Filing  
8/14/2017Linda BaddourVPSell100,000$74.85$7,485,000.00View SEC Filing  
8/14/2017Pra Investors L.P. KkrMajor ShareholderSell9,500,000$74.85$711,075,000.00View SEC Filing  
4/17/2017Linda BaddourVPSell196,393$63.59$12,488,630.87View SEC Filing  
3/28/2017Colin ShannonCEOSell50,000$64.00$3,200,000.00View SEC Filing  
3/27/2017David W DockhornInsiderSell85,182$62.00$5,281,284.00View SEC Filing  
2/23/2017Colin ShannonCEOSell100,000$61.50$6,150,000.00View SEC Filing  
8/22/2016Colin ShannonCEOSell113,133$51.57$5,834,268.81View SEC Filing  
8/15/2016Linda BaddourVPSell69,380$52.00$3,607,760.00View SEC Filing  
8/12/2016David W. DockhornVPSell107,257$49.00$5,255,593.00View SEC Filing  
5/6/2016Linda BaddourCFOSell92,308$46.70$4,310,783.60View SEC Filing  
5/6/2016Pra Investors L.P. KkrMajor ShareholderSell4,907,692$46.70$229,189,216.40View SEC Filing  
3/8/2016Colin ShannonCEOSell77,019$42.26$3,254,822.94View SEC Filing  
3/8/2016Linda BaddourCFOSell93,000$42.26$3,930,180.00View SEC Filing  
3/8/2016Pra Investors L.P. KkrMajor ShareholderSell4,829,981$42.26$204,114,997.06View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for PRA Health Sciences (NASDAQ:PRAH)
Latest Headlines for PRA Health Sciences (NASDAQ PRAH)
Source:
DateHeadline
Earnings Review and Free Research Report: PRA Health Sciences’ Revenue Advanced 28.4%, EPS Surged 49%Earnings Review and Free Research Report: PRA Health Sciences’ Revenue Advanced 28.4%, EPS Surged 49%
finance.yahoo.com - November 17 at 2:07 PM
Teladoc Rides on Growing Demand for Telehealth ServicesTeladoc Rides on Growing Demand for Telehealth Services
finance.yahoo.com - November 15 at 3:33 PM
Critical Analysis: Intellia Therapeutics (NTLA) versus PRA Health Sciences (PRAH)Critical Analysis: Intellia Therapeutics (NTLA) versus PRA Health Sciences (PRAH)
www.americanbankingnews.com - November 15 at 12:06 PM
Intrexon (XON) in Focus: Stock Moves 6.5% HigherIntrexon (XON) in Focus: Stock Moves 6.5% Higher
finance.yahoo.com - November 15 at 7:36 AM
PRA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PRAH-US : November 13, 2017PRA Health Sciences, Inc. breached its 50 day moving average in a Bearish Manner : PRAH-US : November 13, 2017
finance.yahoo.com - November 14 at 6:58 AM
ETFs with exposure to PRA Health Sciences, Inc. : November 13, 2017ETFs with exposure to PRA Health Sciences, Inc. : November 13, 2017
finance.yahoo.com - November 14 at 6:58 AM
PRA Health Sciences, Inc. (PRAH) Given Average Recommendation of "Buy" by AnalystsPRA Health Sciences, Inc. (PRAH) Given Average Recommendation of "Buy" by Analysts
www.americanbankingnews.com - November 13 at 3:04 PM
Excellent Earnings Visibility Metrics Drive Upgrade of PRA Health Sciences (PRAH) to Strong BuyExcellent Earnings Visibility Metrics Drive Upgrade of PRA Health Sciences (PRAH) to Strong Buy
investorplace.com - November 9 at 3:05 PM
 Brokerages Expect PRA Health Sciences, Inc. (PRAH) Will Post Earnings of $1.03 Per Share Brokerages Expect PRA Health Sciences, Inc. (PRAH) Will Post Earnings of $1.03 Per Share
www.americanbankingnews.com - November 8 at 5:28 PM
PRA Health Sciences, Inc. to Post Q3 2018 Earnings of $1.05 Per Share, First Analysis Forecasts (PRAH)PRA Health Sciences, Inc. to Post Q3 2018 Earnings of $1.05 Per Share, First Analysis Forecasts (PRAH)
www.americanbankingnews.com - November 2 at 3:07 PM
PRA Health Sciences, Inc. (PRAH) to Post FY2017 Earnings of $3.19 Per Share, SunTrust Banks ForecastsPRA Health Sciences, Inc. (PRAH) to Post FY2017 Earnings of $3.19 Per Share, SunTrust Banks Forecasts
www.americanbankingnews.com - November 2 at 8:17 AM
Where Bandwidth sits in the Triangles IPO lineupWhere Bandwidth sits in the Triangle's IPO lineup
www.bizjournals.com - November 2 at 7:54 AM
ETFs with exposure to PRA Health Sciences, Inc. : November 1, 2017ETFs with exposure to PRA Health Sciences, Inc. : November 1, 2017
finance.yahoo.com - November 2 at 7:54 AM
PRA Health Sciences (PRAH) PT Raised to $93 at KeyBancPRA Health Sciences (PRAH) PT Raised to $93 at KeyBanc
www.streetinsider.com - October 31 at 8:04 AM
PRA Health Sciences, Inc. :PRAH-US: Earnings Analysis: Q3, 2017 By the Numbers : October 30, 2017PRA Health Sciences, Inc. :PRAH-US: Earnings Analysis: Q3, 2017 By the Numbers : October 30, 2017
finance.yahoo.com - October 31 at 8:04 AM
Analysts Set Expectations for PRA Health Sciences, Inc.s Q4 2017 Earnings (PRAH)Analysts Set Expectations for PRA Health Sciences, Inc.'s Q4 2017 Earnings (PRAH)
www.americanbankingnews.com - October 30 at 6:32 AM
PRA Health Sciences, Inc. (PRAH) Receives "Buy" Rating from SunTrust Banks, Inc.PRA Health Sciences, Inc. (PRAH) Receives "Buy" Rating from SunTrust Banks, Inc.
www.americanbankingnews.com - October 29 at 12:10 AM
PRA Health Sciences (PRAH) CEO Colin Shannon on Q3 2017 Results - Earnings Call Transcript - Seeking AlphaPRA Health Sciences' (PRAH) CEO Colin Shannon on Q3 2017 Results - Earnings Call Transcript - Seeking Alpha
seekingalpha.com - October 28 at 2:19 PM
PRA Health Sciences, Inc. Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance - GlobeNewswire (press release)PRA Health Sciences, Inc. Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance - GlobeNewswire (press release)
globenewswire.com - October 27 at 11:09 AM
PRA Health Sciences, Inc. Reports Third Quarter 2017 Results and Updates Full Year 2017 GuidancePRA Health Sciences, Inc. Reports Third Quarter 2017 Results and Updates Full Year 2017 Guidance
finance.yahoo.com - October 27 at 11:08 AM
PRA Health Sciences tops Street 3Q forecastsPRA Health Sciences tops Street 3Q forecasts
finance.yahoo.com - October 27 at 11:08 AM
PRA Health Sciences, Inc. to Host Earnings CallPRA Health Sciences, Inc. to Host Earnings Call
finance.yahoo.com - October 27 at 11:08 AM
PRA continues tech and data push with new virtual partnerPRA continues tech and data push with new virtual partner
finance.yahoo.com - October 27 at 11:08 AM
Edited Transcript of PRAH earnings conference call or presentation 26-Oct-17 12:00pm GMTEdited Transcript of PRAH earnings conference call or presentation 26-Oct-17 12:00pm GMT
finance.yahoo.com - October 27 at 11:08 AM
PRA Health Sciences, Inc. (PRAH) Issues  Earnings ResultsPRA Health Sciences, Inc. (PRAH) Issues Earnings Results
www.americanbankingnews.com - October 26 at 9:26 PM
PRA Health Sciences, Inc. (PRAH) Receives "Buy" Rating from Credit Suisse GroupPRA Health Sciences, Inc. (PRAH) Receives "Buy" Rating from Credit Suisse Group
www.americanbankingnews.com - October 26 at 4:40 PM
PRA Health Sciences, Inc. (PRAH) Stock Rating Reaffirmed by Jefferies Group LLCPRA Health Sciences, Inc. (PRAH) Stock Rating Reaffirmed by Jefferies Group LLC
www.americanbankingnews.com - October 26 at 2:44 PM
PRA Health Sciences, Inc. (PRAH) Issues FY17 Earnings GuidancePRA Health Sciences, Inc. (PRAH) Issues FY17 Earnings Guidance
www.americanbankingnews.com - October 25 at 6:56 PM
PRA Health Sciences (PRAH) Reports Strategic Partnership with Care Innovations to Utilize Health Harmony PlatformPRA Health Sciences (PRAH) Reports Strategic Partnership with Care Innovations to Utilize Health Harmony Platform
www.streetinsider.com - October 25 at 9:20 AM
Care Innovations® and PRA Health Sciences Announce Strategic PartnershipCare Innovations® and PRA Health Sciences Announce Strategic Partnership
finance.yahoo.com - October 25 at 9:19 AM
PRA Health Sciences, Inc. (PRAH) Scheduled to Post Earnings on TuesdayPRA Health Sciences, Inc. (PRAH) Scheduled to Post Earnings on Tuesday
www.americanbankingnews.com - October 24 at 10:38 AM
What Should We Expect From PRA Health Sciences Inc’s (PRAH) Earnings Over The Next Year?What Should We Expect From PRA Health Sciences Inc’s (PRAH) Earnings Over The Next Year?
finance.yahoo.com - October 22 at 4:22 AM
$474.60 Million in Sales Expected for PRA Health Sciences, Inc. (PRAH) This Quarter$474.60 Million in Sales Expected for PRA Health Sciences, Inc. (PRAH) This Quarter
www.americanbankingnews.com - October 21 at 3:52 AM
Analyzing PRA Health Sciences (PRAH) and Its PeersAnalyzing PRA Health Sciences (PRAH) and Its Peers
www.americanbankingnews.com - October 19 at 10:30 PM
PRA Health Sciences, Inc. (PRAH) Expected to Announce Earnings of $0.84 Per SharePRA Health Sciences, Inc. (PRAH) Expected to Announce Earnings of $0.84 Per Share
www.americanbankingnews.com - October 19 at 10:28 PM
PRA Health Sciences, Inc. (PRAH) Given Average Rating of "Buy" by AnalystsPRA Health Sciences, Inc. (PRAH) Given Average Rating of "Buy" by Analysts
www.americanbankingnews.com - October 19 at 2:36 PM
NovoCure (NVCR) Looks Good: Stock Adds 8.3% in SessionNovoCure (NVCR) Looks Good: Stock Adds 8.3% in Session
finance.yahoo.com - October 17 at 4:13 PM
PRA Health Sciences (PRAH) "Outperform" Rating Reiterated at Credit Suisse GroupPRA Health Sciences' (PRAH) "Outperform" Rating Reiterated at Credit Suisse Group
www.americanbankingnews.com - October 16 at 10:04 AM
No. 1-Ranked Medical Stock Tests Buy Zone Ahead Of EarningsNo. 1-Ranked Medical Stock Tests Buy Zone Ahead Of Earnings
finance.yahoo.com - October 12 at 8:28 AM
Jefferies Group Weighs in on PRA Health Sciences, Inc.s Q4 2017 Earnings (PRAH)Jefferies Group Weighs in on PRA Health Sciences, Inc.'s Q4 2017 Earnings (PRAH)
www.americanbankingnews.com - October 11 at 9:20 AM
PRA Health Sciences, Inc. to Post Q3 2017 Earnings of $0.83 Per Share, William Blair Forecasts (PRAH)PRA Health Sciences, Inc. to Post Q3 2017 Earnings of $0.83 Per Share, William Blair Forecasts (PRAH)
www.americanbankingnews.com - October 11 at 6:32 AM
Head to Head Contrast: PRA Health Sciences (PRAH) & Its RivalsHead to Head Contrast: PRA Health Sciences (PRAH) & Its Rivals
www.americanbankingnews.com - October 10 at 10:21 PM
Brokers Issue Forecasts for PRA Health Sciences, Inc.s Q3 2017 Earnings (PRAH)Brokers Issue Forecasts for PRA Health Sciences, Inc.'s Q3 2017 Earnings (PRAH)
www.americanbankingnews.com - October 10 at 7:22 AM
Society For Clinical Research Sites Announces Winning Sponsor And CRO Of 2017 Eagle Award -- Eli Lilly And INC Research/InVentiv HealthSociety For Clinical Research Sites Announces Winning Sponsor And CRO Of 2017 Eagle Award -- Eli Lilly And INC Research/InVentiv Health
www.thestreet.com - October 10 at 2:23 AM
PRA Health Sciences to Report Third Quarter 2017 EarningsPRA Health Sciences to Report Third Quarter 2017 Earnings
finance.yahoo.com - October 10 at 2:23 AM
PRA Health Sciences, Inc. (PRAH) Given Buy Rating at Robert W. BairdPRA Health Sciences, Inc. (PRAH) Given Buy Rating at Robert W. Baird
www.americanbankingnews.com - October 9 at 4:32 PM
$470.60 Million in Sales Expected for PRA Health Sciences, Inc. (PRAH) This Quarter$470.60 Million in Sales Expected for PRA Health Sciences, Inc. (PRAH) This Quarter
www.americanbankingnews.com - October 3 at 1:18 PM
PRA Health Sciences Clears Key Benchmark, Hitting 80-Plus RS RatingPRA Health Sciences Clears Key Benchmark, Hitting 80-Plus RS Rating
finance.yahoo.com - October 3 at 11:02 AM
 Brokerages Anticipate PRA Health Sciences, Inc. (PRAH) Will Post Earnings of $0.84 Per Share Brokerages Anticipate PRA Health Sciences, Inc. (PRAH) Will Post Earnings of $0.84 Per Share
www.americanbankingnews.com - October 1 at 4:30 AM
PRA Health Sciences, Inc. – Value Analysis (NASDAQ:PRAH) : September 26, 2017PRA Health Sciences, Inc. – Value Analysis (NASDAQ:PRAH) : September 26, 2017
finance.yahoo.com - September 26 at 7:09 PM

Social Media

Financials

Chart

PRA Health Sciences (NASDAQ PRAH) Chart for Friday, November, 17, 2017
Loading chart…

This page was last updated on 11/17/2017 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.